Markets
local & international
Asia Pacific
Currencies
Commodities
UK
North America
News
latest news
Latest News
Most Viewed
Business
Currencies
Economy
Markets
Property
Technology
Portfolio
analysis & tools
Portfolios
Alerts
Filters
Reports
Watchlists
Help
Products
products & services
Charting
Data Agent
Data Subscriptions
Historical Data
Investment Game
Pricing
Real Edge
Download
Login
Register
Saturday, 30 March 2024
ARCA BIOPHARMA INC.
NASDAQ
ABIO
Summary
|
Chart
|
News
|
History
|
More info..
Recent News
More news...
Analysis of Analyst Stock Recommendation:: ARCA biopharma, Inc. (ABIO)
03:26 | 17/3/18
Nasdaq Chronicle
ARCA biopharma, Inc. (ABIO) stock price recent trade pushed it move about -76.09% away from the 52-week high and closed 46.64% away from the 52-week low.
more»
Noteworthy Movers: ARCA biopharma, Inc. (NASDAQ:ABIO), iKang Healthcare Group ...
02:18 | 17/3/18
The Oracle Examiner
ARCA biopharma, Inc., a biopharmaceutical company, develops genetically-targeted therapies for heart failure and cardiovascular diseases.
more»
Technical note to watch on ARCA biopharma, Inc. (ABIO) –
00:03 | 17/3/18
Wall Street Morning
Technical analysis of ARCA biopharma, Inc. (ABIO) stock includes the study of technical indicators and past trends. For technical analysis of stock and trends here we employ the use of tools such as trading volumes, Simple Moving averages, RSI (14 ...
more»
ARCA biopharma, Inc. (NASDAQ:ABIO) – P/E Ratio in Focus
04:33 | 16/3/18
Nasdaq Journal
Shares of ARCA biopharma, Inc. (NASDAQ:ABIO) closed the previous trading session at $0.71, experiencing a change of 15.74% with 1,833,883 shares trading hands.
more»
Vhcp Management Ii, Llc is the third biggest owner of ARCA biopharma, Inc. (ABIO)
01:33 | 16/3/18
Post Analyst
ARCA biopharma, Inc. (NASDAQ:ABIO) enjoyed a 57.56% run-up in share price since hitting record low of $0.45. The stock managed 15.74% rise and now stands at $0.71 as of 03/14/2018.
more»
Ravi Viswanathan Sells 1460209 Shares of Arca Biopharma Inc (NASDAQ:ABIO) Stock
09:48 | 15/3/18
The Ledger Gazette
A hedge fund recently raised its stake in Arca Biopharma stock. Royce & Associates LP raised its stake in Arca Biopharma Inc (NASDAQ:ABIO) by 38.3% during the fourth quarter, according to its most recent filing with the Securities and Exchange ...
more»
Are Analysts Inspiring Confidence in Oasis Petroleum Inc. (OAS), ARCA ...
05:40 | 15/3/18
Post Analyst
According to 31 stock analysts, Oasis Petroleum Inc., is being kept at an average Outperform, rating, with at least 13.71% of shares outstanding that are currently legally short sold.
more»
ARCA biopharma, Inc. (ABIO) stock closes Yesterday with $0.61
03:16 | 15/3/18
Nasdaq Fortune
ARCA biopharma, Inc. (ABIO) shares were closed at $0.61 a share in the latest session and the stock value loss almost -2.76% since the beginning of this year.
more»
Arca Biopharma Inc. (NASDAQ:ABIO) Announces Completion Of Genetic-Af Phase 2b ...
01:00 | 15/3/18
StockAnalyst
ARCA biopharma Inc. (NASDAQ:ABIO) is a biopharmaceutical organization employing clarity medicinal approach to developing therapies on Cardiovascular illness.
more»
Risky factor of ARCA biopharma, Inc. (ABIO) is observed at 1.62
03:20 | 14/3/18
Nasdaq Fortune
ARCA biopharma, Inc. (ABIO) , a stock from Biotechnology Industry, has a value of $0.63 per share, noted a price change of -3.08% in recent trade close.
more»
1
2
3
4
5
6
7
8
9
10
11
next»
Global Indices
Code
Last
Change
COMP
10,321
328
3.08%
DJI
29,635
404
1.34%
SP500
3,583
87
2.37%
DAX
12,438
82
0.67%
FTSE
7,488
5
0.07%
NI225
22,420
408
1.86%
TWI
67.27
0.00
0.00%
More news...
No news available...
Currencies
Code
Last
Change
EURUSD
0.9721
0.0055
0.56%
NZDUSD
0.5548
0.0093
1.65%
AUDUSD
0.6194
0.0107
1.70%
NZDAUD
0.8964
0.0010
0.11%